Brief: Celon Pharma Signs Addenda To Agreements With Tang Capital On Novohale Therapeutics Llc
13/03/2026 16:14
March 13 (Reuters) - Celon Pharma SA CLNP.WA: SIGNS ADDENDA TO AGREEMENTS WITH TANG CAPITAL CONCERNING ESTABLISHING NOVOHALE THERAPEUTICS LLC AMENDED INITIAL CAPITAL OF NOVOHALE IS $30 MILLION, CELON PHARMA'S CONTRIBUTION IS $7 MILLION, TANG CAPITAL'S IS $22.46 MILLION COMPANY'S ECONOMIC SHARE IN NOVOHALE WILL BE 55.1%, WITH 17.9% VOTING SHARE OPTION FOR CELON PHARMA TO BUY OUT TANG CAPITAL'S SHARES IN NOVOHALE IS ELIMINATED Source text: ID:nEMQ9j3fa Further company coverage: CLNP.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))